Pacira Pharmaceuticals(CH:82P)
CH:82P
Pacira Pharmaceuticals earnings date
Pacira Pharmaceuticals (82P) Q2 2024 Earnings Report
0 Followers
CH:82P Q2 2024 EPS Results
- Actual EPS
- CHF 0.75
- Consensus EPS
- CHF 0.59
- Beat/Miss
- Beat by +CHF 0.16
- One Year Ago EPS
- CHF 0.66
CH:82P Q2 2024 Revenue Results
- Actual Revenue
- CHF 149.60M
- Expected Revenue
- CHF 145.97M
- Beat/Miss
- Beat by +CHF 3.63M
- YoY Revenue Growth
- +5.05%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/30/2024
- Time
- After Close
- Conference Call
- Tuesday, July 30, 2024
CH:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:82P Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.48 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.640.59 | 0.59 | -0.29% (-0.00) | |
| Aug 04, 2026 | 2026 (Q2) | 0.540.61 | 0.62 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.460.50 | 0.52 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.760.48 | 0.76 | -37.36% (-0.29) | |
| Nov 06, 2025 | 2025 (Q3) | 0.570.59 | 0.66 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.600.62 | 0.75 | -16.85% (-0.13) | |
| May 08, 2025 | 2025 (Q1) | 0.500.52 | 0.52 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.700.76 | 0.75 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.590.66 | 0.61 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


